- Home
- DXC vs AORT Comparison
DXC vs AORT Comparison
Compare DXC & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DXC | AORT |
|---|---|---|
| Founded | 1959 | 1984 |
| Country | United States | United States |
| Employees | 115000 | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 2016 | 1996 |
Fundamental Metrics
Financial Performance| Metric | DXC | AORT |
|---|---|---|
| Price | $9.44 | $25.18 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $15.00 | ★ $49.40 |
| AVG Volume (30 Days) | ★ 3.4M | 284.3K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | 0.10 | ★ 0.21 |
| Revenue | ★ $12,644,000,000.00 | $298,836,000.00 |
| Revenue This Year | N/A | $14.20 |
| Revenue Next Year | N/A | $11.20 |
| P/E Ratio | ★ $13.71 | $169.71 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $11.07 | $28.07 |
| 52 Week High | $17.26 | $48.25 |
Technical Indicators
Market Signals| Indicator | DXC | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 31.45 | 22.92 |
| Support Level | N/A | N/A |
| Resistance Level | $15.25 | $38.43 |
| Average True Range (ATR) | 0.64 | 2.08 |
| MACD | -0.16 | -0.80 |
| Stochastic Oscillator | 20.56 | 29.80 |
Price Performance
Historical ComparisonAbout DXC DXC Technology Company
DXC Technology Co is a vendor-independent IT services provider. The company's operating segment includes Global Business Services (GBS) and Global Infrastructure Services (GIS). It generates maximum revenue from the GIS segment. GIS offerings include Cloud and Security; IT Outsourcing and Modern Workplace. Geographically, it derives a majority of revenue from the Other Europe region.
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.